Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in DSGN — Design Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$632,743
+$385,215 QoQ
Shares Held
43,728
+88.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. DSGN ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in DSGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $632,743 43,728
2026-03-31 $247,528 23,264
2025-12-31 $257,442 27,446
2025-09-30 $180,018 23,907
2025-06-30 $82,985 24,625
2025-03-31 $85,559 22,166
2024-12-31 $216,936 35,160
2024-09-30 $198,042 36,811
2024-06-30 $108,150 32,284
2024-03-31 $182,949 45,397
2023-12-31 $228,794 86,338
2023-09-30 $115,013 48,735
2023-06-30 $490,631 77,878
2023-03-31 $324,521 56,243
2022-12-31 $3,035,522 295,860
2022-09-30 $1,118,383 66,889
2022-06-30 $391,650 27,975
2022-03-31 $923,763 57,199
2021-12-31 $1,176,200 54,937
2021-09-30 $464,644 31,630
2021-06-30 $127,334 6,402
2021-03-31 $646,467 21,621